From February 21, 2024 to March 31, 2024, the company has repurchased 497,440 shares, representing 0.09% for CNY 28.68 million. With this, the company has completed the repurchase of 497,440 shares, representing 0.09% for CNY 28.68 million under the buyback announced on February 21, 2024.
Autobio Diagnostics Co., Ltd.
Equities
603658
CNE100002GC4
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
57.02 CNY | -0.90% | +1.19% | +0.02% |
Apr. 19 | Autobio Diagnostics' Q1 Profit Jumps 34% | MT |
Apr. 19 | Autobio Diagnostics' 2023 Profit Climbs 4% as Operating Income Stays Flat | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.02% | 4.57B | |
-1.89% | 12.56B | |
-9.59% | 7.68B | |
-1.31% | 5.29B | |
+21.82% | 5.18B | |
-50.89% | 3.29B | |
+6.42% | 2.6B | |
-10.02% | 2.2B | |
-8.29% | 1.79B | |
+1.72% | 1.76B |
- Stock Market
- Equities
- 603658 Stock
- News Autobio Diagnostics Co., Ltd.
- Tranche Update on Autobio Diagnostics Co., Ltd.'s Equity Buyback Plan announced on February 21, 2024.